According to the latest report by India Ratings and Research (Ind-Ra), the Indian pharmaceutical market is witnessing strong growth and is expected to reach a CAGR of 8-9 per cent in 2026.
The projected growth for FY 2025 also remains significant, reaching 7.5-8 per cent. This is reported by ANI, a partner of TV BRICS.
Krishnanath Munde, associate director at India Ratings and Research, said the growth for FY 2024 was 6.5 per cent.
The 12-month sales of pharmaceuticals rose 8.1 per cent in February. Cardiology drugs were the best performers, up 10.8 per cent. They were followed by gastroenterological, neurological, and dermatological drugs.
African Times published this article in partnership with International Media Network TV BRICS
